Skip to main content
. 2017 May 23;14(1):885–890. doi: 10.3892/ol.2017.6231

Figure 2.

Figure 2.

Kaplan-Meier plots of the post-progression survival in patients with EGFR mutations in the tumor vs. patients with wild-type EGFR in the tumor. EGFR, epidermal growth factor receptor; bold line, EGFR mutation group; dashed line, EGFR wild type.